Global Hereditary Angioedema Therapeutic Market Seeking Excellent GrowthPosted by Rashi Pande on December 9th, 2019 Market Analysis: Global Hereditary Angioedema Therapeutic MarketGlobal hereditary angioedema therapeutic market is expected to rise to an estimated value of USD 4.51 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increased awareness about hereditary angioedema in various regions. Market Definition: Global Hereditary Angioedema Therapeutic MarketHereditary angioedema is a rare genetic disorder. The common symptoms of the disease are repeated incidents of severe swelling limbs, intestinal tract, face, and airway. This disease is categorized into three categories: Type I HAE, Type II HAE, Type III HAE. As per NIH Organization report, hereditary angioedema affects almost 1 in 50,000 people. The prevalence rate of Type I is more, which represents almost 85% of cases, the prevalence of Type II is 15% of, and the incidence of Type III is very rare. Market Drivers:
Market Restraints:
Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hereditary-angioedema-therapeutic-market Segmentation: Global Hereditary Angioedema Therapeutic MarketBy Type
By Drug Class
By Application
By Route of Administration
By End-User
By Distribution Channel
By Geography
Key Developments in the Market:
Competitive Analysis Global hereditary angioedema therapeutic market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hereditary angioedema therapeutic market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. Major Market Competitors/Players Few of the major competitors currently working in the global hereditary angioedema therapeutic market are Takeda Pharmaceutical Company Limited; CSL Limited; BIOCRYST PHARMACEUTICALS, INC.; Pharming Group N.V.; Ionis Pharmaceuticals; Novartis AG; CENTOGENE AG; Sanofi; KalVista Pharmaceuticals among others. Like it? Share it!More by this author |